Prevalence of asymptomatic left ventricular systolic dysfunction in at-risk medical inpatients

American Journal of Medicine

Volumn 126, Issue 1, 2013, Pages 68-73

  Martin, L David ^a   Mathews, Simon ^a   Ziegelstein, Roy C ^a   Martire, Carol ^a   Howell, Eric E ^a   Hellmann, David B ^a   Hirsch, Glenn A ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Echocardiography; Epidemiology; Hand carried ultrasound; Heart failure; Portable ultrasound; Systolic function

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; BALTIMORE; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84871615926     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.06.020     Document Type: Article

References (31)

1. D.D. Schocken, E.J. Benjamin, G.C. Fonarow Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research: Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Circulation 117 19 2008 2544 2565
2. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 14 2009 e391 e479
3. A. Azevedo, P. Bettencourt, P. Dias Population based study on the prevalence of the stages of heart failure Heart 92 8 2006 1161 1163
4. K.A. Ammar, S.J. Jacobsen, D.W. Mahoney Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community Circulation 115 12 2007 1563 1570
5. J.J. Atherton Screening for left ventricular systolic dysfunction: is imaging a solution? JACC Cardiovasc Imaging 3 4 2010 421 428
6. T.J. Wang, J.C. Evans, E.J. Benjamin Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982
7. G. D'Ambrosio, A. Filippi, R. Labriola Identification of patients with asymptomatic left ventricular systolic dysfunction: 'real practice' results in primary care Fam Pract 27 4 2010 359 362
8. S. Carerj, S. La Carrubba, F. Antonini-Canterin The incremental prognostic value of echocardiography in asymptomatic stage A heart failure J Am Soc Echocardiogr 23 2010 1025 1034
9. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
10. D.W. Baker, R.C. Bahler, R.S. Finkelhor, M.S. Lauer Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure Am Heart J 146 4 2003 736 740
11. F.D. Hobbs, A.K. Roalfe, R.C. Davis Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES) Eur Heart J 28 2007 1128 1134
12. M.A. Pfeffer, E. Braunwald, L.A. Moye Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 10 1992 669 677
13. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions The SOLVD Investigators N Engl J Med 327 10 1992 685 691
14. P. Jong, S. Yusuf, M.F. Rousseau Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study Lancet 361 2003 1843 1848
15. V. Madhok, G. Falk, A. Rogers The accuracy of symptoms, signs and diagnostic tests in the diagnosis of left ventricular dysfunction in primary care: a diagnostic accuracy systematic review BMC Fam Pract 9 2008 56
16. R.S. Vasan, E.J. Benjamin, M.G. Larson Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study JAMA 288 10 2002 1252 1259
17. C. Luers, R. Wachter, S. Kleta Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction Clin Res Cardiol 99 2010 217 226
18. C. Davenport, E.Y. Cheng, Y.T. Kwok Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis Br J Gen Pract 56 2006 48 56
19. M.J. Liebo, R.L. Israel, E.O. Lillie Is pocket mobile echocardiography the next-generation stethoscope? A cross-sectional comparison of rapidly acquired images with standard transthoracic echocardiography Ann Intern Med 8 2 2011 161 173
20. G.I. Galasko, S.C. Barnes, P. Collinson, A. Lahiri, R. Senior What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 27 2006 193 200
21. J.M. Wilson, G. Jungner Principles and Practices of Screening for Disease 1968 World Health Organization Geneva
22. A. Andermann, I. Blancquaert, S. Beauchamp, V. Dery Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years Bull World Health Organ 86 2008 317 319
23. S. Fedson, G. Neithardt, P. Thomas Unsuspected clinically important findings detected with a small portable ultrasound device in patients admitted to a general medicine service J Am Soc Echocardiogr 16 9 2003 901 905
24. E.C. Vourvouri, A.F. Schinkel, J.R. Roelandt Screening for left ventricular dysfunction using a hand-carried cardiac ultrasound device Eur J Heart Fail 5 2003 767 774
25. G.I. Galasko, A. Lahiri, R. Senior Portable echocardiography: an innovative tool in screening for cardiac abnor-malities in the community Eur J Echocardiogr 4 2003 119 127
26. K.T. Spencer, A.S. Anderson, A. Bhargava Physician-performed point-of-care echocardiography using a laptop platform compared with physical examination in the cardiovascular patient J Am Coll Cardiol 37 8 2001 2013 2018
27. L.D. Martin, E.E. Howell, R.C. Ziegelstein Hospitalist performance of cardiac hand-carried ultrasound after focused training Am J Med 20 2007 1000 1004
28. K.E. Mondy, J. Gottdiener, E.T. Overton High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy Clin Infect Dis 52 3 2011 378 386
29. S. Kenchaiah, J. Narula, R.S. Vasan Risk factors for heart failure Med Clin North Am 88 5 2004 1145 1172
30. J. He, L.G. Ogden, L.A. Bazzano Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study Arch Intern Med 161 2001 996 1002
31. B.J. Kimura, N. Yogo, C.W. O'Connell Cardiopulmonary limited ultrasound examination for "quick-look" bedside application Am J Cardiol 108 4 2011 586 590